Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A04AA01	ONZO	G	Ondansetron (HCl dihydrate) - 4mg/5ml	4mg/5ml	Solution	2,687,685 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 10mg	10mg	Tablet, film coated	224,503,943 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 5mg	5mg	Tablet, film coated	224,503,943 L.L
A08AB01	ONLEFIT	G	Orlistat - 120mg	120mg	Capsule	1,537,356 L.L
A08AB01	ORLISTAT	G	Orlistat - 120mg	120mg	Capsule, hard	847,965 L.L
A08AB01	ORLISTAT-SIGMA	G	Orlistat - 120mg	120mg	Capsule	847,965 L.L
A08AB01	ORLY SLIM	G	Orlistat - 120mg	120mg	Capsule	1,174,518 L.L
A10BB12	ORBIDE	G	Glimepiride - 1mg	1mg	Tablet	207,336 L.L
A10BB12	ORBIDE	G	Glimepiride - 2mg	2mg	Tablet	209,895 L.L
A10BB12	ORBIDE	G	Glimepiride - 3mg	3mg	Tablet	351,959 L.L
A10BB12	ORBIDE	G	Glimepiride - 4mg	4mg	Tablet	357,078 L.L
A10BD02	ORBIZIDE M FORTE	G	Metformin HCl - 500mg, Gliclazide - 80mg		Tablet	771,750 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.25mg	0.25mg	Injectable solution	10,927,526 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 0.5mg	0.5mg	Injectable solution	10,927,526 L.L
A10BJ06	OZEMPIC	B	Semaglutide - 1mg	1mg	Injectable solution	10,927,526 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	2,218,684 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	4,219,665 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 1mcg	1mcg	Capsule	3,735,882 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Drops solution	1,343,843 L.L
A11CC05	OSTEODYN VITAMINE D3	G	Vitamin D3 - 100000IU/2ml	100000IU/2ml	Solution	618,168 L.L
A11CC05	ORAVIL	G	Vitamin D3 - 100,000IU/2ml	100,000IU	Solution	618,168 L.L
A12AX	OSTRONG	G	Vitamin D3 - 500IU, Calcium hydrogen phosphate - 600mg		Tablet	435,149 L.L
B02BD01	OCTAPLEX	BioHuman	Prothrombin complex, human (PPSB) - 500IU	500IU	Injectable powder for solution+diluent	35,220,164 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	13,247,110 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	26,495,478 L.L
B02BD02	OCTANATE	BioHuman	Coagulation Factor VIII - 1,000IU	1,000IU	Injectable lyophilised powder for solution+diluent	46,817,511 L.L
B02BD04	OCTANINE F	BioHuman	Plasma coagulation factor IX, human - 500IU	500IU	Injectable freeze dried powder + diluent	31,425,075 L.L

...